MIT Libraries logoDSpace@MIT

MIT
View Item 
  • DSpace@MIT Home
  • MIT Libraries
  • MIT Theses
  • Doctoral Theses
  • View Item
  • DSpace@MIT Home
  • MIT Libraries
  • MIT Theses
  • Doctoral Theses
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

In vivo activation and biocompatibility of a MEMS microreservoir drug delivery device

Author(s)
Shawgo, Rebecca Scheidt, 1976-
Thumbnail
DownloadFull printable version (5.498Mb)
Other Contributors
Massachusetts Institute of Technology. Dept. of Materials Science and Engineering.
Advisor
Michael J. Cima.
Terms of use
M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. http://dspace.mit.edu/handle/1721.1/7582
Metadata
Show full item record
Abstract
Temporal and spatial control over the delivery of therapeutic compounds is an important, fertile, and rapidly advancing field of study in medicine. This work describes the advancement of a new technology of drug delivery from a benchtop prototype releasing tracer molecules to an implantable device for initial animal studies. The improved MEMS (micro-electro-mechanical systems) device was used for the subcutaneous delivery of both tracer molecules (fluorescein and mannitol) and a chemotherapeutic agent (carmustine) in rats. Both temporal and spatial profiles of the tracer molecules were established; only the temporal kinetics of the carmustine were studied. The MEMS drug delivery device is based on a silicon substrate into which microreservoirs are etched. Each reservoir contains an individual dosage of drug and is independently addressable. The microreservoirs are covered with gold membranes which act as anodes. The application of an anodic voltage, in an aqueous solution containing chloride ions, electrochemically transforms gold into gold chloride which is readily soluble in water. This device allows the delivery of both solid and liquid drugs of a wide variety of compositions.
 
(cont.) It is important to study the biocompatibility of the device activation process as well as that of the component materials since the activation of the MEMS drug delivery device depends on an electrochemical reaction. Other researchers have studied the biological response to gold, silicon, silicon dioxide and silicon nitride; however, few studies of the effect of voltage applications, particularly of gold electrochemistry, have ever been performed. The effects of both electrochemical dissolution of a macroscopic gold film electrode and the repeated electrochemical activation of gold MEMS microelectrodes on the immune response and fibrous capsule formation were observed, as well as the effect of long term implantation on gold electrochemistry.
 
Description
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Materials Science and Engineering, 2004.
 
"June 2004."
 
Includes bibliographical references.
 
Date issued
2004
URI
http://hdl.handle.net/1721.1/17678
Department
Massachusetts Institute of Technology. Department of Materials Science and Engineering
Publisher
Massachusetts Institute of Technology
Keywords
Materials Science and Engineering.

Collections
  • Doctoral Theses

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

Login

Statistics

OA StatisticsStatistics by CountryStatistics by Department
MIT Libraries
PrivacyPermissionsAccessibilityContact us
MIT
Content created by the MIT Libraries, CC BY-NC unless otherwise noted. Notify us about copyright concerns.